|
G |
Myo15a |
myosin XVA |
induces |
IAGP |
DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat) compared to LEW/Ztm |
RGD |
PMID:21479269 PMID:21479269 |
RGD:150429616, RGD:150429616 |
NCBI chr10:45,776,907...45,835,473
|
|
G |
Myo15aci2 |
myosin XVA; ci2 mutant |
induces |
IAGP |
compared to LEW/Ztm |
RGD |
PMID:21479269 |
RGD:150429616 |
|
|
|
G |
Pax6 |
paired box 6 |
|
IAGP |
|
RGD |
PMID:9247338 |
RGD:731242 |
NCBI chr 3:92,128,772...92,157,022
|
|
G |
Pax6Sey2 |
paired box gene 6, small eye mutation 2 |
|
IAGP |
|
RGD |
PMID:9247338 |
RGD:731242 |
|
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
|
IMP |
|
RGD |
PMID:32841724 |
RGD:150530292 |
NCBI chr 8:55,369,794...55,398,526
|
|
G |
Chrna5em20(D398N)Pas |
cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 20,Pas |
|
IMP |
|
RGD |
PMID:32841724 |
RGD:150530292 |
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
IMP |
compared to wild type littermate |
RGD |
PMID:18581099 |
RGD:4889490 |
NCBI chr10:62,322,688...62,357,060
|
|
G |
Slc6a4m1Hubr |
solute carrier family 6 member 4; ZFN induced mutant1, Hubr |
|
IMP |
compared to wild type littermate |
RGD |
PMID:18581099 |
RGD:4889490 |
|
|
G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
|
IMP |
|
RGD |
PMID:26988269 PMID:24555056 |
RGD:126848803, RGD:126848805 |
NCBI chr 2:138,307,676...138,476,856
|
|
G |
Trpc4Tn(sb)Tngen |
transient receptor potential cation channel, subfamily C, member 4; sleeping beauty induced mutant, Tngen |
|
IMP |
|
RGD |
PMID:24555056 PMID:26988269 |
RGD:126848805, RGD:126848803 |
|
|
|
G |
Add3 |
adducin 3 |
|
IMP |
|
RGD |
PMID:32029431 |
RGD:150340736 |
NCBI chr 1:262,152,722...262,260,504
|
|
|
G |
Mecp2 |
methyl CpG binding protein 2 |
|
IMP |
|
RGD |
PMID:27313794 |
RGD:11568037 |
NCBI chr X:156,932,481...156,995,981
|
|
G |
Mecp2em1Sage |
methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:27313794 |
RGD:11568037 |
|
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
IAGP |
|
RGD |
PMID:11832364 |
RGD:727991 |
NCBI chr 7:108,719,349...108,726,024
|
|
|
G |
Tspo |
translocator protein |
induces |
IMP |
|
RGD |
PMID:29074640 |
RGD:150429771 |
NCBI chr 7:116,600,214...116,610,461
|
|
G |
Tspoem1Vpl |
translocator protein; ZFN induced mutant1, Vpl |
induces |
IMP |
|
RGD |
PMID:29074640 |
RGD:150429771 |
|
|
G |
Tspoem2Vpl |
translocator protein; ZFN induced mutant2, Vpl |
induces |
IMP |
|
RGD |
PMID:29074640 |
RGD:150429771 |
|
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
IMP |
|
RGD |
PMID:26077568 |
RGD:13800514 |
NCBI chr19:50,307,569...50,312,812
|
|
G |
Hsd11b2em1Jmul |
hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul |
|
IMP |
|
RGD |
PMID:26077568 |
RGD:13800514 |
|
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
IMP |
|
RGD |
PMID:26077568 |
RGD:13800514 |
NCBI chr19:50,307,569...50,312,812
|
|
G |
Hsd11b2em1Jmul |
hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul |
|
IMP |
|
RGD |
PMID:26077568 |
RGD:13800514 |
|
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
IMP |
|
RGD |
PMID:26077568 |
RGD:13800514 |
NCBI chr19:50,307,569...50,312,812
|
|
G |
Hsd11b2em1Jmul |
hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul |
|
IMP |
|
RGD |
PMID:26077568 |
RGD:13800514 |
|
|
|
G |
Dhh |
desert hedgehog signaling molecule |
|
IMP |
|
RGD |
PMID:21062903 |
RGD:38548923 |
NCBI chr 7:130,050,910...130,056,406
|
|
|
G |
Depdc5 |
DEP domain containing 5, GATOR1 subcomplex subunit |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
NCBI chr14:81,956,777...82,087,392
|
|
G |
Depdc5em1Kyo |
DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
|
|
G |
Depdc5em2Kyo |
DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
IMP |
|
RGD |
PMID:36536454 |
RGD:401976434 |
NCBI chr X:147,240,239...147,278,057
|
|
G |
Fmr1em1Sage |
FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:36536454 |
RGD:401976434 |
|
|
G |
Scn9a |
sodium voltage-gated channel alpha subunit 9 |
induces |
IMP |
|
RGD |
PMID:31550995 |
RGD:150429745 |
NCBI chr 3:71,553,185...71,701,377
|
|
G |
Scn9a*tm1Amgn |
sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn |
induces |
IMP |
|
RGD |
PMID:31550995 |
RGD:150429745 |
|
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
IMP |
|
RGD |
PMID:22842522 |
RGD:7207891 |
NCBI chr 7:95,483,105...95,488,031
|
|
|
G |
Apoe |
apolipoprotein E |
|
IMP |
|
RGD |
PMID:29166645 |
RGD:150520219 |
NCBI chr 1:88,481,889...88,485,816
|
|
G |
Apoeem1Ejt |
apolipoprotein E; TALEN induced mutant 1, Ejt |
|
IMP |
|
RGD |
PMID:29166645 |
RGD:150520219 |
|
|
G |
Apoeem1Sage |
apolipoprotein E; endonuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:29166645 |
RGD:150520219 |
|
|
|
G |
Lepr |
leptin receptor |
|
IAGP |
DNA:mutations:cds: : (rat) |
RGD |
PMID:32710530 |
RGD:401960103 |
NCBI chr 5:121,409,735...121,593,201
|
|
|
G |
Lepr |
leptin receptor |
|
IAGP |
DNA:mutations:cds: : (rat) |
RGD |
PMID:32710530 |
RGD:401960103 |
NCBI chr 5:121,409,735...121,593,201
|
|
|
G |
Crh |
corticotropin releasing hormone |
|
IDA |
|
RGD |
PMID:11908464 |
RGD:704423 |
NCBI chr 2:104,059,184...104,061,048
|
|
|
G |
Cryba1 |
crystallin, beta A1 |
|
IMP |
|
RGD |
PMID:17931883 |
RGD:2303652 |
NCBI chr10:62,608,373...62,614,726
|
|
G |
Cryba1Nuc1Dbsa |
crystallin, beta A1;Nuc1 mutant, Dbsa |
|
IMP |
|
RGD |
PMID:17931883 |
RGD:2303652 |
|
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
IMP |
compared to wild type |
RGD |
PMID:34751141 |
RGD:405100968 |
NCBI chr X:147,240,239...147,278,057
|
|
G |
Fmr1em1Sage |
FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
compared to wild type |
RGD |
PMID:34751141 |
RGD:405100968 |
|
|
|
G |
Cntnap2 |
contactin associated protein 2 |
|
IMP |
peak amplitudes and transmission latency |
RGD |
PMID:30126973 |
RGD:126790476 |
NCBI chr 4:74,109,455...76,366,434
|
|
G |
Cntnap2em1Sage |
contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
peak amplitudes and transmission latency |
RGD |
PMID:30126973 |
RGD:126790476 |
|
|
G |
Myo7a |
myosin VIIA |
|
IAGP |
DNA:nonsense mutation:cds |
RGD |
PMID:15965244 |
RGD:1581470 |
NCBI chr 1:152,342,611...152,414,171
|
|
G |
Myo7atnd/Hubr |
myosin VIIA; ENU induced tornado mutant, Hubr |
|
IAGP |
DNA:nonsense mutation:cds |
RGD |
PMID:15965244 |
RGD:1581470 |
|
|
G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
|
IMP |
|
RGD |
PMID:29970986 |
RGD:126790534 |
NCBI chr 1:208,575,144...209,020,300
|
|
G |
Shank2em13Sage |
SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage |
|
IMP |
|
RGD |
PMID:29970986 |
RGD:126790534 |
|
|
|
G |
Cryba1 |
crystallin, beta A1 |
|
IMP |
|
RGD |
PMID:21266465 |
RGD:126925759 |
NCBI chr10:62,608,373...62,614,726
|
|
G |
Cryba1Nuc1Dbsa |
crystallin, beta A1;Nuc1 mutant, Dbsa |
|
IMP |
|
RGD |
PMID:21266465 |
RGD:126925759 |
|
|
|
G |
Edaradd |
EDAR associated via death domain |
|
IAGP |
DNA:missense mutation:exon:p.Pro153Ser(rat) |
RGD |
PMID:22013926 |
RGD:14398762 |
NCBI chr17:85,866,629...85,910,612
|
|
G |
EdaraddswhKyo |
EDAR-associated death domain;swh Kyo mutant |
|
IAGP |
DNA:missense mutation:exon:p.Pro153Ser(rat) |
RGD |
PMID:22013926 |
RGD:14398762 |
|
|
|
G |
Ctnnd2 |
catenin delta 2 |
|
IMP |
|
RGD |
PMID:32554807 |
RGD:407532699 |
NCBI chr 2:81,168,525...82,016,495
|
|
|
G |
Cacna1f |
calcium voltage-gated channel subunit alpha1 F |
|
IAGP |
DNA:mutation:cds: c.2941C>T (rat) |
RGD |
PMID:18246026 |
RGD:13782370 |
NCBI chr X:14,868,096...14,896,413
|
|
G |
Cacna1f csnb |
calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant |
|
IAGP |
DNA:mutation:cds: c.2941C>T (rat) |
RGD |
PMID:18246026 |
RGD:13782370 |
|
|
|
G |
Myo15a |
myosin XVA |
induces |
IAGP |
DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat) compared to LEW/Ztm |
RGD |
PMID:21479269 PMID:21479269 |
RGD:150429616, RGD:150429616 |
NCBI chr10:45,776,907...45,835,473
|
|
G |
Myo15aci2 |
myosin XVA; ci2 mutant |
induces |
IAGP |
compared to LEW/Ztm |
RGD |
PMID:21479269 |
RGD:150429616 |
|
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
|
IMP |
|
RGD |
PMID:31644904 |
RGD:126925983 |
NCBI chr16:7,771,311...7,841,895
|
|
G |
Ercc6em1Cgen |
ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen |
|
IMP |
|
RGD |
PMID:31644904 |
RGD:126925983 |
|
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IAGP |
|
RGD |
PMID:11814400 |
RGD:1581462 |
NCBI chr 8:58,605,403...58,669,339
|
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
IMP |
knock-out compared to wild-type rats |
RGD |
PMID:30283001 |
RGD:38501063 |
NCBI chr 8:116,158,810...116,171,857
|
|
G |
Grm2em1 |
glutamate metabotropic receptor 2; endonuclease induced mutant 1 |
|
IMP |
KO compared to wild-type rats |
RGD |
PMID:30283001 |
RGD:38501063 |
|
|
|
G |
Pax6 |
paired box 6 |
|
IAGP |
DNA:frameshift mutation:cds: |
RGD |
PMID:21203536 |
RGD:8552339 |
NCBI chr 3:92,128,772...92,157,022
|
|
G |
Pax6Sey2 |
paired box gene 6, small eye mutation 2 |
|
IAGP |
compared to SD |
RGD |
PMID:21203536 |
RGD:8552339 |
|
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
IMP |
knock-out compared to wild-type rats |
RGD |
PMID:30283001 |
RGD:38501063 |
NCBI chr 8:116,158,810...116,171,857
|
|
G |
Grm2em1 |
glutamate metabotropic receptor 2; endonuclease induced mutant 1 |
|
IMP |
KO compared to wild-type rats |
RGD |
PMID:30283001 |
RGD:38501063 |
|
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
IMP |
knock-out compared to wild-type rats |
RGD |
PMID:30283001 |
RGD:38501063 |
NCBI chr 8:116,158,810...116,171,857
|
|
G |
Grm2em1 |
glutamate metabotropic receptor 2; endonuclease induced mutant 1 |
|
IMP |
KO compared to wild-type rats |
RGD |
PMID:30283001 |
RGD:38501063 |
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
IMP |
|
RGD |
PMID:22049154 |
RGD:8657330 |
NCBI chr 4:26,312,403...26,488,456
|
|
G |
Abcb1aem2Sage |
ATP binding cassette subfamily B member 1A; ZFN induced mutant 2, Sage |
|
IMP |
|
RGD |
PMID:22049154 |
RGD:8657330 |
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
IAGP |
|
RGD |
PMID:12663688 |
RGD:704399 |
NCBI chr 1:252,613,875...252,672,459
|
|
G |
Crh |
corticotropin releasing hormone |
|
IDA |
|
RGD |
PMID:12663088 |
RGD:704425 |
NCBI chr 2:104,059,184...104,061,048
|
|
|
G |
Tmem67 |
transmembrane protein 67 |
|
IAGP |
|
RGD |
PMID:30705305 |
RGD:14995942 |
NCBI chr 5:30,333,793...30,386,702
|
|
G |
Tmem67wpk |
transmembrane protein 67; wpk mutant |
|
IAGP |
|
RGD |
PMID:30705305 |
RGD:14995942 |
|
|
|
G |
Esr1 |
estrogen receptor 1 |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
NCBI chr 1:43,511,685...43,904,454
|
|
G |
Esr1em1Soar |
estrogen receptor 1; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
|
|
|
G |
Cckar |
cholecystokinin A receptor |
|
IAGP |
|
RGD |
PMID:15178543 |
RGD:1625204 |
NCBI chr14:57,292,397...57,300,747
|
|
|
G |
Prkg2 |
protein kinase cGMP-dependent 2 |
|
IAGP |
DNA:deletion:cds (rat) |
RGD |
PMID:15466490 |
RGD:150429792 |
NCBI chr14:10,864,020...10,972,617
|
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
IAGP |
|
RGD |
PMID:12379742 |
RGD:628338 |
NCBI chr 2:198,065,400...198,084,774
|
|
G |
Csf1tl |
colony stimulating factor 1; tooth less mutant |
|
IAGP |
|
RGD |
PMID:12379742 |
RGD:628338 |
|
|
|
G |
F8 |
coagulation factor VIII |
treatment |
IMP |
|
RGD |
PMID:27060449 |
RGD:150520059 |
NCBI chr18:140,848...172,330
|
|
G |
F8em1Sage |
coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage |
treatment |
IMP |
|
RGD |
PMID:27060449 |
RGD:150520059 |
|
|
|
G |
Arsb |
arylsulfatase B |
|
IAGP |
|
RGD |
PMID:21887218 |
RGD:39131283 |
NCBI chr 2:25,002,210...25,162,675
|
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
IMP |
|
RGD |
PMID:33450391 |
RGD:126781687 |
NCBI chr18:56,834,152...56,860,804
|
|
G |
Csf1rtm(EGFP)Tset |
colony stimulating factor 1 receptor; target mutant, Tset |
|
IMP |
|
RGD |
PMID:33450391 |
RGD:126781687 |
|
|
G |
Dcx |
doublecortin |
|
IMP |
|
RGD |
PMID:14625554 |
RGD:1304461 |
NCBI chr X:107,430,767...107,573,612
|
|
|
G |
Ar |
androgen receptor |
|
IAGP |
|
RGD |
PMID:17490813 |
RGD:10043338 |
NCBI chr X:63,104,771...63,273,934
|
|
|
G |
Nlgn3 |
neuroligin 3 |
|
IMP |
|
RGD |
PMID:28958035 |
RGD:126790492 |
NCBI chr X:66,427,926...66,457,378
|
|
G |
Nlgn3em1Sage |
neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:28958035 |
RGD:126790492 |
|
|
|
G |
Cyfip1 |
cytoplasmic FMR1 interacting protein 1 |
|
IMP |
|
RGD |
PMID:31371763 |
RGD:14981598 |
NCBI chr 1:115,842,754...115,935,163
|
|
G |
Cyfip1em1Sage |
cytoplasmic FMR1 interacting protein 1; CRISPR/Cas9 induced mutant 1, Sage |
|
IMP |
|
RGD |
PMID:31371763 |
RGD:14981598 |
|
|
|
G |
Wfs1 |
wolframin ER transmembrane glycoprotein |
onset |
IMP |
|
RGD |
PMID:28860598 |
RGD:149735331 |
NCBI chr14:73,810,478...73,834,993
|
|
G |
Wfs1em1Ptsn |
wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 |
onset |
IMP |
|
RGD |
PMID:28860598 |
RGD:149735331 |
|
|
|
G |
Tbc1d1 |
TBC1 domain family member 1 |
induces |
IMP |
|
RGD |
PMID:28808062 |
RGD:150521563 |
NCBI chr14:44,289,241...44,489,246
|
|
G |
Tbc1d1Tn(sb)1Fkh |
TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh |
induces |
IMP |
|
RGD |
PMID:28808062 |
RGD:150521563 |
|
|
|
G |
Ttn |
titin |
|
IAGP |
|
RGD |
PMID:27869827 |
RGD:11565821 |
NCBI chr 3:82,059,648...82,332,130
|
|
G |
Ttnem1Sage |
Titin; zinc finger nuclease induced mutant 1,Sigma Advanced Genetic Engineering Labs |
|
IAGP |
|
RGD |
PMID:27869827 |
RGD:11565821 |
|
|
G |
Ttnem2Sage |
Titin; zinc finger nuclease induced mutant 2,Sigma Advanced Genetic Engineering Labs |
|
IAGP |
|
RGD |
PMID:27869827 |
RGD:11565821 |
|
|
|
G |
Tnnt2 |
troponin T2, cardiac type |
|
IDA |
|
RGD |
PMID:10946062 |
RGD:1580434 |
NCBI chr13:49,819,123...49,837,125
|
|
|
G |
Kcnq1 |
potassium voltage-gated channel subfamily Q member 1 |
|
IAGP |
DNA:deletion:exon (rat) |
RGD |
PMID:16368876 |
RGD:1581602 |
NCBI chr 1:207,721,134...208,054,073
|
|
G |
Kcnq1dfk |
potassium voltage-gated channel subfamily Q member 1;deafness Kyoto |
|
IAGP |
|
RGD |
PMID:16368876 |
RGD:1581602 |
|
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
|
IMP |
|
RGD |
PMID:32231239 |
RGD:32716373 |
NCBI chr 7:64,756,626...64,761,570
|
|
G |
Cyp27b1em1Thka |
cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka |
|
IMP |
|
RGD |
PMID:32231239 |
RGD:32716373 |
|
|
G |
Vdr |
vitamin D receptor |
|
IMP |
|
RGD |
PMID:32231239 |
RGD:32716373 |
NCBI chr 7:130,864,764...130,916,757
|
|
G |
Vdrem1Thka |
vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka |
|
IMP |
|
RGD |
PMID:32231239 |
RGD:32716373 |
|
|
G |
Vdrem2Thka |
vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka |
|
IMP |
|
RGD |
PMID:32231239 |
RGD:32716373 |
|
|
|
G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
|
IAGP |
|
RGD |
PMID:17434290 |
RGD:15036800 |
NCBI chr 1:18,557,091...19,056,297
|
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
IMP |
|
RGD |
PMID:22842522 |
RGD:7207891 |
NCBI chr 7:95,483,105...95,488,031
|
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
|
IMP |
|
RGD |
PMID:31644904 |
RGD:126925983 |
NCBI chr16:7,771,311...7,841,895
|
|
G |
Ercc6em1Cgen |
ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen |
|
IMP |
|
RGD |
PMID:31644904 |
RGD:126925983 |
|
|
|
G |
Pclo |
piccolo (presynaptic cytomatrix protein) |
|
IMP |
compared to wild-type rat |
RGD |
PMID:31074746 |
RGD:41408338 |
NCBI chr 4:19,691,439...20,050,015
|
|
G |
PcloTn(sb-B-Geo)Fkh |
presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh |
|
IMP |
compared to wild-type rat |
RGD |
PMID:31074746 |
RGD:41408338 |
|
|
|
G |
Ccdc39 |
coiled-coil domain 39 molecular ruler complex subunit |
|
IMP |
|
RGD |
PMID:31771992 |
RGD:150521527 |
NCBI chr 2:116,665,651...116,703,354
|
|
G |
Ccdc39em1Jgn |
coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn |
|
IMP |
|
RGD |
PMID:31771992 |
RGD:150521527 |
|
|
G |
Tmem67 |
transmembrane protein 67 |
|
IAGP |
|
RGD |
PMID:30705305 |
RGD:14995942 |
NCBI chr 5:30,333,793...30,386,702
|
|
G |
Tmem67wpk |
transmembrane protein 67; wpk mutant |
|
IAGP |
|
RGD |
PMID:30705305 |
RGD:14995942 |
|
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
|
IMP |
|
RGD |
PMID:19160503 |
RGD:529195970 |
NCBI chr 2:168,247,490...168,367,616
|
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
IMP |
|
RGD |
PMID:24608905 |
RGD:11566051 |
NCBI chr 4:47,422,084...47,694,646
|
|
G |
Cftrem1Sage |
cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage |
|
IMP |
|
RGD |
PMID:24608905 |
RGD:11566051 |
|
|
|
G |
Cd36 |
CD36 molecule |
|
IAGP |
|
RGD |
PMID:18288886 |
RGD:2307226 |
NCBI chr 4:18,209,088...18,302,142
|
|
|
G |
Cryba1 |
crystallin, beta A1 |
|
IAGP |
|
RGD |
PMID:26303524 |
RGD:38676460 |
NCBI chr10:62,608,373...62,614,726
|
|
G |
Cryba1Hiser |
crystallin, beta A1; HiSER mutant |
|
IAGP |
|
RGD |
PMID:26303524 |
RGD:38676460 |
|
|
G |
Tmem67 |
transmembrane protein 67 |
|
IAGP |
|
RGD |
PMID:30705305 |
RGD:14995942 |
NCBI chr 5:30,333,793...30,386,702
|
|
G |
Tmem67wpk |
transmembrane protein 67; wpk mutant |
|
IAGP |
|
RGD |
PMID:30705305 |
RGD:14995942 |
|
|
|
G |
Astn1 |
astrotactin 1 |
|
IMP |
|
RGD |
PMID:24714719 |
RGD:12792227 |
NCBI chr13:70,537,423...70,855,440
|
|
G |
Brinp2 |
BMP/retinoic acid inducible neural specific 2 |
|
IMP |
|
RGD |
PMID:24714719 |
RGD:12792227 |
NCBI chr13:70,431,006...70,532,766
|
|
G |
Cop1 |
COP1, E3 ubiquitin ligase |
|
IMP |
|
RGD |
PMID:24714719 |
RGD:12792227 |
NCBI chr13:73,954,058...74,095,283
|
|
G |
Pappa2 |
pappalysin 2 |
|
IMP |
|
RGD |
PMID:24714719 |
RGD:12792227 |
NCBI chr13:70,873,918...71,147,874
|
|
G |
Tnr |
tenascin R |
|
IMP |
|
RGD |
PMID:24714719 |
RGD:12792227 |
NCBI chr13:71,751,714...72,172,731
|
|
|
G |
Esr2 |
estrogen receptor 2 |
|
IMP |
|
RGD |
PMID:29580824 |
RGD:38548925 |
NCBI chr 6:100,589,553...100,645,240
|
|
G |
Esr2em1Soar |
estrogen receptor 2; ZFN induced mutant 1, Soar |
|
IMP |
compared to wild type |
RGD |
PMID:29580824 |
RGD:38548925 |
|
|
|
G |
Lrrk2 |
leucine-rich repeat kinase 2 |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
NCBI chr 7:124,706,246...124,867,234
|
|
G |
Lrrk2em1Sage |
leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
|
|
|
G |
Il1rl2 |
interleukin 1 receptor-like 2 |
|
IMP |
compared to Wild Type in cardiopulmonary bypass model |
RGD |
PMID:32048631 |
RGD:126925167 |
NCBI chr 9:42,591,658...42,639,351
|
|
G |
Il1rl2tm1(Myh6-cre)Mhzh |
interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh |
|
IMP |
compared to Wild Type in cardiopulmonary bypass model |
RGD |
PMID:32048631 |
RGD:126925167 |
|
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 |
RGD:401976418 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 |
RGD:401976418 |
|
|
|
G |
Il1rl2 |
interleukin 1 receptor-like 2 |
|
IMP |
compared to Wild Type in cardiopulmonary bypass model |
RGD |
PMID:32048631 |
RGD:126925167 |
NCBI chr 9:42,591,658...42,639,351
|
|
G |
Il1rl2tm1(Myh6-cre)Mhzh |
interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh |
|
IMP |
compared to Wild Type in cardiopulmonary bypass model |
RGD |
PMID:32048631 |
RGD:126925167 |
|
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
IMP |
|
RGD |
PMID:24608905 |
RGD:11566051 |
NCBI chr 4:47,422,084...47,694,646
|
|
G |
Cftrem1Sage |
cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage |
|
IMP |
|
RGD |
PMID:24608905 |
RGD:11566051 |
|
|
|
G |
Ednrb |
endothelin receptor type B |
|
IAGP |
|
RGD |
PMID:8570650 |
RGD:628515 |
NCBI chr15:87,055,490...87,086,765
|
|
G |
Ednrbsl |
endothelin receptor type B, spotting lethal |
|
IAGP |
|
RGD |
PMID:8570650 |
RGD:628515 |
|
|
G |
Rab38 |
RAB38, member RAS oncogene family |
|
IAGP |
DNA:point mutation:exon:p.M1I |
RGD |
PMID:15112108 |
RGD:1300411 |
NCBI chr 1:142,182,566...142,262,923
|
|
G |
Rab38ru |
Rab38, member of RAS oncogene family, ruby allele |
|
IAGP |
DNA:point mutation:exon:p.M1I (rat) |
RGD |
PMID:15112108 |
RGD:1300411 |
|
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
IMP |
KO compared to wild-type rats |
RGD |
PMID:28700935 |
RGD:38501064 |
NCBI chr 8:116,158,810...116,171,857
|
|
G |
Grm2em1 |
glutamate metabotropic receptor 2; endonuclease induced mutant 1 |
|
IMP |
KO compared to wild-type rats |
RGD |
PMID:28700935 |
RGD:38501064 |
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
IMP |
|
RGD |
PMID:30144237 |
RGD:401938631 |
NCBI chr10:62,322,688...62,357,060
|
|
G |
Slc6a4m1Hubr |
solute carrier family 6 member 4; ZFN induced mutant1, Hubr |
|
IMP |
|
RGD |
PMID:30144237 |
RGD:401938631 |
|
|
|
G |
Myo7a |
myosin VIIA |
|
IAGP |
DNA:nonsense mutation:cds |
RGD |
PMID:15965244 |
RGD:1581470 |
NCBI chr 1:152,342,611...152,414,171
|
|
G |
Myo7atnd/Hubr |
myosin VIIA; ENU induced tornado mutant, Hubr |
|
IAGP |
DNA:nonsense mutation:cds |
RGD |
PMID:15965244 |
RGD:1581470 |
|
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
ameliorates |
IMP |
|
RGD |
PMID:39156650 |
RGD:407571672 |
NCBI chr 8:123,586,100...123,634,178
|
|
|
G |
Lepr |
leptin receptor |
treatment |
IAGP |
compared to treated |
RGD |
PMID:33568522 |
RGD:401965412 |
NCBI chr 5:121,409,735...121,593,201
|
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IDA |
decreased after administration of D2 antagonist |
RGD |
PMID:11311883 |
RGD:1581463 |
NCBI chr 8:58,605,403...58,669,339
|
|
|
G |
Twf1 |
twinfilin actin-binding protein 1 |
|
IMP |
|
RGD |
PMID:33963280 |
RGD:596938166 |
NCBI chr 7:127,595,210...127,607,821
|
|
|
G |
Prkcz |
protein kinase C, zeta |
|
IDA |
inhibition eliminates long term memory of taste aversion stimulus |
RGD |
PMID:17702943 |
RGD:1642657 |
NCBI chr 5:171,101,774...171,212,694
|
|
|
G |
Cacna1f |
calcium voltage-gated channel subunit alpha1 F |
|
IAGP |
DNA:mutation:cds: c.2941C>T (rat) |
RGD |
PMID:18246026 |
RGD:13782370 |
NCBI chr X:14,868,096...14,896,413
|
|
G |
Cacna1f csnb |
calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant |
|
IAGP |
DNA:mutation:cds: c.2941C>T (rat) |
RGD |
PMID:18246026 |
RGD:13782370 |
|
|
|
G |
Nkx3-1 |
NK3 homeobox 1 |
|
IMP |
compared to wild type |
RGD |
PMID:33368416 |
RGD:150573817 |
NCBI chr15:44,473,851...44,476,443
|
|
G |
Nkx3-1em1Pjhak |
NK3 homeobox 1; TALEN induced mutant 1, Pjhak |
|
IMP |
compared to wild type |
RGD |
PMID:33368416 |
RGD:150573817 |
|
|
|
G |
L1cam |
L1 cell adhesion molecule |
|
IMP |
|
RGD |
PMID:30738385 |
RGD:14695001 |
NCBI chr X:151,597,270...151,623,776
|
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
IMP |
|
RGD |
PMID:33450391 |
RGD:126781687 |
NCBI chr18:56,834,152...56,860,804
|
|
G |
Csf1rtm(EGFP)Tset |
colony stimulating factor 1 receptor; target mutant, Tset |
|
IMP |
|
RGD |
PMID:33450391 |
RGD:126781687 |
|
|
|
G |
Nell1 |
neural EGFL like 1 |
|
IMP |
|
RGD |
PMID:12235118 |
RGD:633405 |
NCBI chr 1:99,709,305...100,573,872
|
|
|
G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
IMP |
|
RGD |
PMID:20531371 |
RGD:13825198 |
NCBI chr 5:78,024,139...78,147,071
|
|
G |
Lpar1m1Hubr |
lysophosphatidic acid receptor 1; ENU induced mutant 1, Hubr |
|
IMP |
|
RGD |
PMID:20531371 |
RGD:13825198 |
|
|
|
G |
Cdh13 |
cadherin 13 |
|
IMP |
knock-out compared to wild-type rats |
RGD |
PMID:28387990 |
RGD:13503340 |
NCBI chr19:46,349,562...47,387,462
|
|
G |
Cdh13em1Mcwi |
cadherin 13; zinc finger nuclease induced mutant 1, Medical College of Wisconsin |
|
IMP |
knock-out compared to wild-type rats |
RGD |
PMID:28387990 |
RGD:13503340 |
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
IMP |
knock-out compared to wild-type rats knockout compared to wild type |
RGD |
PMID:30283001 PMID:28700935 |
RGD:38501063, RGD:38501064 |
NCBI chr 8:116,158,810...116,171,857
|
|
G |
Grm2em1 |
glutamate metabotropic receptor 2; endonuclease induced mutant 1 |
|
IMP |
KO compared to wild-type rats |
RGD |
PMID:28700935 PMID:30283001 |
RGD:38501064, RGD:38501063 |
|
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
|
IMP |
|
RGD |
PMID:19160503 |
RGD:529195970 |
NCBI chr 2:168,247,490...168,367,616
|
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
IGI |
Myh9 NMIIA RGDID 3140 |
RGD |
PMID:28199848 |
RGD:151347403 |
NCBI chr20:3,047,269...3,069,277
|
|
|
G |
Ilk |
integrin-linked kinase |
|
IMP |
inhibition in the nucleus accumbens decreases dendrite density of medium spiny neurons |
RGD |
PMID:18602949 |
RGD:2301736 |
NCBI chr 1:169,500,716...169,506,972
|
|
|
G |
Kdr |
kinase insert domain receptor |
|
IDA |
|
RGD |
PMID:17360578 |
RGD:2292006 |
NCBI chr14:32,572,031...32,615,204
|
|
G |
Plcb1 |
phospholipase C beta 1 |
|
IDA |
|
RGD |
PMID:15536495 |
RGD:1582557 |
NCBI chr 3:122,059,988...122,772,896
|
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
IMP |
|
RGD |
PMID:26077568 |
RGD:13800514 |
NCBI chr19:50,307,569...50,312,812
|
|
G |
Hsd11b2em1Jmul |
hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul |
|
IMP |
|
RGD |
PMID:26077568 |
RGD:13800514 |
|
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
IMP |
|
RGD |
PMID:32051532 |
RGD:126925233 |
NCBI chr 8:19,440,611...19,486,659
|
|
G |
Dnmt1tm1(Myh6-cre)Cqin |
DNA methyltransferase 1; tm1(Myh6-cre), Cqin |
|
IMP |
|
RGD |
PMID:32051532 |
RGD:126925233 |
|
|
|
G |
Comt |
catechol-O-methyltransferase |
|
IDA |
|
RGD |
PMID:12535946 |
RGD:704422 |
NCBI chr11:96,072,371...96,091,956
|
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
|
RGD |
PMID:14568317 |
RGD:1626460 |
NCBI chr 3:67,370,794...67,452,422
|
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
|
IMP |
|
RGD |
PMID:37190555 |
RGD:596933068 |
NCBI chr 2:168,247,490...168,367,616
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
ameliorates |
IMP |
|
RGD |
PMID:23671067 |
RGD:401938637 |
NCBI chr10:6,136,458...6,560,003
|
|
|
G |
Themis |
thymocyte selection associated |
|
IAGP |
DNA:frameshift mutation: |
RGD |
PMID:22275874 |
RGD:38599149 |
NCBI chr 1:16,433,906...16,623,889
|
|
G |
Themism1Adej |
thymocyte selection associated; mutant1, Adej |
|
IAGP |
compared to BN |
RGD |
PMID:22275874 |
RGD:38599149 |
|
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
IMP |
|
RGD |
PMID:31942562 |
RGD:126928119 |
NCBI chr 4:47,422,084...47,694,646
|
|
G |
Cftrem1Ang |
cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang |
|
IMP |
|
RGD |
PMID:31942562 |
RGD:126928119 |
|
|
G |
Cftrem2Ang |
cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang |
|
IMP |
|
RGD |
PMID:31942562 |
RGD:126928119 |
|
|
|
G |
Prkg2 |
protein kinase cGMP-dependent 2 |
|
IAGP |
DNA:deletion:cds (rat) |
RGD |
PMID:19149413 |
RGD:150429793 |
NCBI chr14:10,864,020...10,972,617
|
|
|
G |
Pax6 |
paired box 6 |
|
IAGP |
|
RGD |
PMID:17178107 |
RGD:12790972 |
NCBI chr 3:92,128,772...92,157,022
|
|
G |
Tbc1d1 |
TBC1 domain family member 1 |
induces |
IMP |
compared to Wild type |
RGD |
PMID:28177704 |
RGD:150521607 |
NCBI chr14:44,289,241...44,489,246
|
|
G |
Tbc1d1Tn(sb)1Fkh |
TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh |
induces |
IMP |
compared to Wild type |
RGD |
PMID:28177704 |
RGD:150521607 |
|
|
|
G |
Myo5a |
myosin VA |
|
IAGP |
DNA:rearrangement, deletion:exon:141-bp deletion position 1442-1582 |
RGD |
PMID:17185506 |
RGD:1600835 |
NCBI chr 8:84,692,524...84,860,564
|
|
G |
Tg |
thyroglobulin |
|
IAGP |
DNA:missense mutation:cds:p.G2320R (rat) |
RGD |
PMID:11089535 |
RGD:730133 |
NCBI chr 7:98,418,293...98,603,210
|
|
G |
Tgrdw |
thyroglobulin; rdw mutant |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:11089535 |
RGD:730133 |
|
|
|
G |
Lepr |
leptin receptor |
treatment |
IAGP |
compared to treated |
RGD |
PMID:33568522 |
RGD:401965412 |
NCBI chr 5:121,409,735...121,593,201
|
|
|
G |
Ednrb |
endothelin receptor type B |
|
IAGP |
|
RGD |
PMID:9739043 PMID:8570650 |
RGD:628516, RGD:628515 |
NCBI chr15:87,055,490...87,086,765
|
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
IMP |
Por |
RGD |
PMID:27856527 |
RGD:127285625 |
NCBI chr11:75,965,717...76,006,733
|
|
G |
Nr1i2em1Sage |
nuclear receptor subfamily 1, group I, member 2; ZFN induced mutant1, Sage |
|
IMP |
Por |
RGD |
PMID:27856527 |
RGD:127285625 |
|
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
IMP |
|
RGD |
PMID:29190650 |
RGD:151347176 |
NCBI chr 4:47,422,084...47,694,646
|
|
G |
Cftrem1Sage |
cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage |
|
IMP |
|
RGD |
PMID:29190650 |
RGD:151347176 |
|
|
|
G |
Egfr |
epidermal growth factor receptor |
|
IDA |
|
RGD |
PMID:11796513 |
RGD:70386 |
NCBI chr14:95,378,626...95,551,358
|
|
G |
Inha |
inhibin subunit alpha |
|
IDA |
rat transgene introduced into female mice |
RGD |
PMID:15359127 |
RGD:2290396 |
NCBI chr 9:84,443,109...84,446,010
|
|
|
G |
Prkar1b |
protein kinase cAMP-dependent type I regulatory subunit beta |
|
IMP |
|
RGD |
PMID:33479380 |
RGD:150519900 |
NCBI chr12:15,492,233...15,624,942
|
|
G |
Prkar1bem2Tua |
protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua |
|
IMP |
|
RGD |
PMID:33479380 |
RGD:150519900 |
|
|
|
G |
P2ry2 |
purinergic receptor P2Y2 |
|
IMP |
|
RGD |
PMID:19155635 |
RGD:2316657 |
NCBI chr 1:164,764,119...164,779,578
|
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
IMP |
knockout compared to wild type |
RGD |
PMID:28700935 |
RGD:38501064 |
NCBI chr 8:116,158,810...116,171,857
|
|
G |
Grm2em1 |
glutamate metabotropic receptor 2; endonuclease induced mutant 1 |
|
IMP |
KO compared to wild-type rats |
RGD |
PMID:28700935 |
RGD:38501064 |
|
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
induces |
IMP |
compared to standard diet |
RGD |
PMID:29656108 |
RGD:150520032 |
NCBI chr 5:116,295,691...116,323,219
|
|
G |
Cyp2j4em1Sage |
cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage |
induces |
IMP |
compared to standard diet |
RGD |
PMID:29656108 |
RGD:150520032 |
|
|
|
G |
Pax6 |
paired box 6 |
|
QTM |
|
RGD |
PMID:9247338 |
RGD:731242 |
NCBI chr 3:92,128,772...92,157,022
|
|
|
G |
Pax6 |
paired box 6 |
|
IAGP |
|
RGD |
PMID:7981749 |
RGD:1601213 |
NCBI chr 3:92,128,772...92,157,022
|
|
G |
Pax6Sey |
paired box gene 6, small eye mutation |
|
IAGP |
|
RGD |
PMID:7981749 |
RGD:1601213 |
|
|
|
G |
Frem2 |
FRAS1 related extracellular matrix 2 |
|
IAGP |
|
RGD |
PMID:21756877 |
RGD:13464328 |
NCBI chr 2:137,602,784...137,740,785
|
|
G |
Frem2fpl |
Fras1 related extracellular matrix protein 2;fpl mutant |
|
IAGP |
|
RGD |
PMID:21756877 |
RGD:13464328 |
|
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
IAGP |
|
RGD |
PMID:27381370 |
RGD:127285618 |
NCBI chr 4:150,095,743...150,221,104
|
|
G |
Ppargm1Kyo |
peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo |
|
IAGP |
|
RGD |
PMID:27381370 |
RGD:127285618 |
|
|
|
G |
Htr1b |
5-hydroxytryptamine receptor 1B |
|
IDA |
|
RGD |
PMID:12040062 |
RGD:625756 |
NCBI chr 8:91,395,405...91,414,815
|
|
|
G |
Esr1 |
estrogen receptor 1 |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
NCBI chr 1:43,511,685...43,904,454
|
|
G |
Esr1em1Soar |
estrogen receptor 1; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
|
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
treatment |
IMP |
compared to Jcl:Wi and untreated |
RGD |
PMID:32231239 |
RGD:32716373 |
NCBI chr 7:64,756,626...64,761,570
|
|
G |
Cyp27b1em1Thka |
cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka |
treatment |
IMP |
compared to Jcl:Wi and untreated |
RGD |
PMID:32231239 |
RGD:32716373 |
|
|
G |
Lrp5 |
LDL receptor related protein 5 |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
NCBI chr 1:200,814,247...200,917,581
|
|
G |
Lrp5em1Vari |
LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
|
|
G |
Lrp5em2Vari |
LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
|
|
G |
Lrp5em3Vari |
LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
|
|
G |
Vdr |
vitamin D receptor |
|
IMP |
|
RGD |
PMID:32231239 |
RGD:32716373 |
NCBI chr 7:130,864,764...130,916,757
|
|
G |
Vdrem1Thka |
vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka |
|
IMP |
|
RGD |
PMID:32231239 |
RGD:32716373 |
|
|
|
G |
Dhh |
desert hedgehog signaling molecule |
|
IMP |
|
RGD |
PMID:21062903 |
RGD:38548923 |
NCBI chr 7:130,050,910...130,056,406
|
|
|
G |
Mc4r |
melanocortin 4 receptor |
|
IMP |
|
RGD |
PMID:21527895 |
RGD:6478803 |
NCBI chr18:62,689,798...62,691,685
|
|
|
G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
|
IAGP |
DNA:missense mutation:cds:G369E (rat) |
RGD |
PMID:27472223 |
RGD:39131293 |
NCBI chr 1:191,945,809...191,950,480
|
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
|
IMP |
compared to wild type SS rat |
RGD |
PMID:30354811 |
RGD:39939000 |
NCBI chr12:15,217,217...15,222,679
|
|
G |
Gper1em1Bj |
G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj |
|
IMP |
compared to wild type SS rat |
RGD |
PMID:30354811 |
RGD:39939000 |
|
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
|
IAGP |
|
RGD |
PMID:17196942 |
RGD:1598976 |
NCBI chr19:40,425,560...40,724,810
|
|
G |
Cplx1 |
complexin 1 |
|
IMP |
|
RGD |
PMID:31875236 |
RGD:127285808 |
NCBI chr14:1,184,677...1,216,392
|
|
G |
Mkx |
mohawk homeobox |
|
IMP |
compared to Wistar |
RGD |
PMID:27370800 |
RGD:40924660 |
NCBI chr17:55,077,073...55,156,877
|
|
G |
Mkxem1Asah |
mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah |
|
IMP |
compared to Wistar |
RGD |
PMID:27370800 |
RGD:40924660 |
|
|
G |
Park7 |
Parkinsonism associated deglycase |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
NCBI chr 5:166,636,551...166,659,825
|
|
G |
Park7em1Sage |
parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
|
|
G |
Pink1 |
PTEN induced kinase 1 |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
NCBI chr 5:155,813,838...155,825,950
|
|
G |
Pink1em1Sage |
PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
|
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
IMP |
compared to wild type rats in response to ghrelin (CHEBI:75431) |
RGD |
PMID:21258824 |
RGD:150520012 |
NCBI chr 2:110,268,489...110,271,865
|
|
G |
Ghsrm1Mcwi |
growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin |
|
IMP |
compared to wild type rats in response to ghrelin (CHEBI:75431) |
RGD |
PMID:21258824 |
RGD:150520012 |
|
|
|
G |
Lepr |
leptin receptor |
|
IMP |
|
RGD |
PMID:27465994 |
RGD:12911217 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Leprem2Mcwi |
leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:27465994 |
RGD:12911217 |
|
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
compared to wild type |
RGD |
PMID:29563343 PMID:34541380 PMID:34320241 |
RGD:150429980, RGD:401976419, RGD:401976418 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
|
IMP |
compared to wild type |
RGD |
PMID:29563343 PMID:34541380 PMID:34320241 |
RGD:150429980, RGD:401976419, RGD:401976418 |
|
|
|
G |
Aqp4 |
aquaporin 4 |
|
IMP |
|
RGD |
PMID:33574749 |
RGD:127284879 |
NCBI chr18:6,782,389...6,799,034
|
|
G |
Aqp4em1Hrt |
aquaporin 4; TALEN induced mutant 1, Hrt |
|
IMP |
|
RGD |
PMID:33574749 |
RGD:127284879 |
|
|
G |
Ccdc39 |
coiled-coil domain 39 molecular ruler complex subunit |
|
IMP |
|
RGD |
PMID:31771992 |
RGD:150521527 |
NCBI chr 2:116,665,651...116,703,354
|
|
G |
Ccdc39em1Jgn |
coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn |
|
IMP |
|
RGD |
PMID:31771992 |
RGD:150521527 |
|
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
NCBI chr19:59,338,402...60,269,323
|
|
G |
Wwoxlde |
WW domain-containing oxidoreductase; lde mutant |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
|
|
|
G |
Cntnap2 |
contactin associated protein 2 |
|
IMP |
in young animals |
RGD |
PMID:30126973 |
RGD:126790476 |
NCBI chr 4:74,109,455...76,366,434
|
|
G |
Cntnap2em1Sage |
contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
in young animals |
RGD |
PMID:30126973 |
RGD:126790476 |
|
|
G |
Nrg1 |
neuregulin 1 |
|
IMP |
|
RGD |
PMID:21620900 |
RGD:405650204 |
NCBI chr16:65,954,084...67,007,484
|
|
G |
Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:21620900 |
RGD:405650204 |
|
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
IMP |
|
RGD |
PMID:36536454 |
RGD:401976434 |
NCBI chr X:147,240,239...147,278,057
|
|
G |
Fmr1em1Sage |
FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:36536454 |
RGD:401976434 |
|
|
G |
Nrxn1 |
neurexin 1 |
|
IMP |
|
RGD |
PMID:25420124 |
RGD:12914797 |
NCBI chr 6:3,177,788...4,323,848
|
|
G |
Nrxn1em1 |
neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:25420124 |
RGD:12914797 |
|
|
|
G |
Krt71 |
keratin 71 |
|
IAGP |
DNA:deletion:cds:intron 1, p.Val149_Gln154 del |
RGD |
PMID:20179389 |
RGD:11570415 |
NCBI chr 7:132,873,532...132,898,975
|
|
G |
Krt71Rex |
keratin 71; autosomal dominant Rex |
|
IAGP |
DNA:deletion:cds:intron 1, p.Val149_Gln154 del |
RGD |
PMID:20179389 |
RGD:11570415 |
|
|
|
G |
Foxn1 |
forkhead box N1 |
|
IAGP |
|
RGD |
PMID:8790387 |
RGD:1300512 |
NCBI chr10:63,749,461...63,778,468
|
|
G |
Krt83 |
keratin 83 |
|
IAGP |
DNA:deletion |
RGD |
PMID:18420582 |
RGD:2316553 |
NCBI chr 7:132,604,180...132,610,869
|
|
G |
Krt87 |
keratin 87 |
|
IAGP |
DNA:deletion |
RGD |
PMID:18420582 |
RGD:2316553 |
NCBI chr 7:132,547,388...132,555,005
|
|
|
G |
Edaradd |
EDAR associated via death domain |
|
IAGP |
compared to heterozygous animals |
RGD |
PMID:15829729 |
RGD:2304219 |
NCBI chr17:85,866,629...85,910,612
|
|
G |
EdaraddswhKyo |
EDAR-associated death domain;swh Kyo mutant |
|
IAGP |
compared to heterozygous animals |
RGD |
PMID:15829729 |
RGD:2304219 |
|
|
|
G |
Tmem67 |
transmembrane protein 67 |
|
IAGP |
|
RGD |
PMID:30705305 |
RGD:14995942 |
NCBI chr 5:30,333,793...30,386,702
|
|
G |
Tmem67wpk |
transmembrane protein 67; wpk mutant |
|
IAGP |
|
RGD |
PMID:30705305 |
RGD:14995942 |
|
|
|
G |
Tmem67 |
transmembrane protein 67 |
|
IAGP |
|
RGD |
PMID:30705305 |
RGD:14995942 |
NCBI chr 5:30,333,793...30,386,702
|
|
G |
Tmem67wpk |
transmembrane protein 67; wpk mutant |
|
IAGP |
|
RGD |
PMID:30705305 |
RGD:14995942 |
|
|
|
G |
Dmd |
dystrophin |
|
IMP |
|
RGD |
PMID:25310701 |
RGD:12880034 |
NCBI chr X:51,070,098...53,437,845
|
|
G |
Dmdem1Ang |
dystrophin; TALEN-induced mutant1, Ang |
|
IMP |
|
RGD |
PMID:25310701 |
RGD:12880034 |
|
|
|
G |
Lepr |
leptin receptor |
treatment |
IAGP |
|
RGD |
PMID:33568522 |
RGD:401965412 |
NCBI chr 5:121,409,735...121,593,201
|
|
|
G |
F8 |
coagulation factor VIII |
treatment |
IMP |
|
RGD |
PMID:31899798 |
RGD:150520060 |
NCBI chr18:140,848...172,330
|
|
G |
F8em1Sage |
coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage |
treatment |
IMP |
|
RGD |
PMID:31899798 |
RGD:150520060 |
|
|
G |
F8em1Mcwi |
coagulation factor VIII, procoagulant component; CRISPR/Cas9 induced mutant1, Mcwi |
treatment |
IMP |
|
RGD |
PMID:31899798 |
RGD:150520060 |
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
IMP |
|
RGD |
PMID:19246633 |
RGD:4889487 |
NCBI chr10:62,322,688...62,357,060
|
|
|
G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
|
IAGP |
DNA:missense mutation:cds:G369E (rat) |
RGD |
PMID:27472223 |
RGD:39131293 |
NCBI chr 1:191,945,809...191,950,480
|
|
|
G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
|
IMP |
|
RGD |
PMID:29970986 |
RGD:126790534 |
NCBI chr 1:208,575,144...209,020,300
|
|
G |
Shank2em13Sage |
SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage |
|
IMP |
|
RGD |
PMID:29970986 |
RGD:126790534 |
|
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
IMP |
|
RGD |
PMID:36536454 |
RGD:401976434 |
NCBI chr X:147,240,239...147,278,057
|
|
G |
Fmr1em1Sage |
FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:36536454 |
RGD:401976434 |
|
|
|
G |
Pax6 |
paired box 6 |
|
IAGP |
|
RGD |
PMID:9247338 |
RGD:731242 |
NCBI chr 3:92,128,772...92,157,022
|
|
G |
Pax6Sey2 |
paired box gene 6, small eye mutation 2 |
|
IAGP |
|
RGD |
PMID:9247338 |
RGD:731242 |
|
|
|
G |
Themis |
thymocyte selection associated |
|
IAGP |
DNA:frameshift mutation: |
RGD |
PMID:22275874 |
RGD:38599149 |
NCBI chr 1:16,433,906...16,623,889
|
|
G |
Themism1Adej |
thymocyte selection associated; mutant1, Adej |
|
IAGP |
compared to BN |
RGD |
PMID:22275874 |
RGD:38599149 |
|
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
IMP |
|
RGD |
PMID:27071940 |
RGD:12910550 |
NCBI chr 3:81,001,529...81,031,165
|
|
G |
Nfe2l2em1Kyo |
nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 1, Kyoto University |
|
IMP |
|
RGD |
PMID:27071940 |
RGD:12910550 |
|
|
G |
Nfe2l2em2Kyo |
nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 2, Kyoto University |
|
IMP |
|
RGD |
PMID:27071940 |
RGD:12910550 |
|
|
|
G |
Lep |
leptin |
|
IMP |
|
RGD |
PMID:22948215 |
RGD:12904911 |
NCBI chr 4:58,626,529...58,640,663
|
|
G |
Lepem1Sage |
leptin; zinc finger nuclease induced mutant1, Sage |
|
IMP |
|
RGD |
PMID:22948215 |
RGD:12904911 |
|
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
|
IMP |
|
RGD |
PMID:17322067 |
RGD:12910822 |
NCBI chr14:32,901,615...32,978,895
|
|
G |
KitWs |
KIT proto-oncogene receptor tyrosine kinase; mutant 1 |
|
IMP |
|
RGD |
PMID:17322067 |
RGD:12910822 |
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
IMP |
|
RGD |
PMID:22049154 |
RGD:8657330 |
NCBI chr 4:26,312,403...26,488,456
|
|
G |
Abcb1aem2Sage |
ATP binding cassette subfamily B member 1A; ZFN induced mutant 2, Sage |
|
IMP |
|
RGD |
PMID:22049154 |
RGD:8657330 |
|
|
|
G |
Men1 |
menin 1 |
severity |
IMP |
|
RGD |
PMID:15054094 |
RGD:1304318 |
NCBI chr 1:203,638,905...203,644,871
|
|
|
G |
Cplx1 |
complexin 1 |
|
IMP |
|
RGD |
PMID:31875236 |
RGD:127285808 |
NCBI chr14:1,184,677...1,216,392
|
|
|
G |
Mir200c |
microRNA 200c |
treatment |
IMP |
|
RGD |
PMID:23272142 |
RGD:155882562 |
NCBI chr 4:157,523,679...157,523,747
|
|
|
G |
Grk6 |
G protein-coupled receptor kinase 6 |
|
IMP |
associated with Parkinson Disease |
RGD |
PMID:20410529 |
RGD:5684919 |
NCBI chr17:9,182,160...9,198,380
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
treatment |
IMP |
|
RGD |
PMID:29530712 |
RGD:40924655 |
NCBI chr 7:132,368,399...132,389,300
|
|
G |
Nr4a1m1Mcwi |
nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin |
treatment |
IMP |
|
RGD |
PMID:29530712 |
RGD:40924655 |
|
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
|
IAGP |
|
RGD |
PMID:9448300 PMID:14675167 |
RGD:729808, RGD:1580428 |
NCBI chr 7:131,503,076...131,540,246
|
|
|
G |
Themis |
thymocyte selection associated |
|
IAGP |
DNA:frameshift mutation: |
RGD |
PMID:22275874 |
RGD:38599149 |
NCBI chr 1:16,433,906...16,623,889
|
|
G |
Themism1Adej |
thymocyte selection associated; mutant1, Adej |
|
IAGP |
compared to BN |
RGD |
PMID:22275874 |
RGD:38599149 |
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Ahrem2Sage |
aryl hydrocarbon receptor; ZFN induced mutant2, Sage |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
|
|
|
G |
Fh |
fumarate hydratase |
|
IMP |
|
RGD |
PMID:27556703 |
RGD:13792708 |
NCBI chr13:90,056,565...90,082,450
|
|
G |
Fhem1 |
fumarate hydratase; TALEN induced mutant 1 |
|
IMP |
|
RGD |
PMID:27556703 |
RGD:13792708 |
|
|
G |
Ren |
renin |
exacerbates |
IMP |
compared to wild type |
RGD |
PMID:21242461 |
RGD:7771614 |
NCBI chr13:47,348,312...47,359,539
|
|
G |
Renem1Mcwi |
renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin |
exacerbates |
IMP |
compared to wild type |
RGD |
PMID:21242461 |
RGD:7771614 |
|
|
|
G |
Depdc5 |
DEP domain containing 5, GATOR1 subcomplex subunit |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
NCBI chr14:81,956,777...82,087,392
|
|
G |
Depdc5em1Kyo |
DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
|
|
G |
Depdc5em2Kyo |
DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
|
|
|
G |
Comt |
catechol-O-methyltransferase |
|
TAS |
|
RGD |
PMID:12535946 |
RGD:704422 |
NCBI chr11:96,072,371...96,091,956
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
|
IMP |
in hemizygote mutant male (LAMP2y/-) |
RGD |
PMID:29720683 |
RGD:13703117 |
NCBI chr X:122,038,734...122,087,745
|
|
G |
Lamp2em1 |
lysosomal-associated membrane protein 2; TALEN induced mutant1 |
|
IMP |
in hemizygote mutant male (LAMP2y/-) |
RGD |
PMID:29720683 |
RGD:13703117 |
|
|
G |
Rin1 |
Ras and Rab interactor 1 |
|
IMP |
|
RGD |
PMID:32174475 |
RGD:126790555 |
NCBI chr 1:202,355,729...202,362,731
|
|
G |
Rin1em1Hcz |
Ras and Rab interactor 1; TALEN induced mutant 1, Hcz |
|
IMP |
|
RGD |
PMID:32174475 |
RGD:126790555 |
|
|
|
G |
Gja8 |
gap junction protein, alpha 8 |
|
IAGP |
DNA:missense mutation:cds:p.L7Q(rat) |
RGD |
PMID:18470322 |
RGD:2293186 |
NCBI chr 2:184,490,840...184,492,456
|
|
G |
Gja8m1Cub |
gap junction protein, alpha 8; mutant 1 Cub |
|
IAGP |
|
RGD |
PMID:18470322 |
RGD:2293186 |
|
|
|
G |
Gla |
galactosidase, alpha |
severity |
IMP |
compared to wild type |
RGD |
PMID:31253878 |
RGD:401976417 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
severity |
IMP |
compared to wild type |
RGD |
PMID:31253878 |
RGD:401976417 |
|
|
|
G |
Cryba1 |
crystallin, beta A1 |
|
IAGP |
|
RGD |
PMID:26303524 |
RGD:38676460 |
NCBI chr10:62,608,373...62,614,726
|
|
G |
Cryba1Hiser |
crystallin, beta A1; HiSER mutant |
|
IAGP |
|
RGD |
PMID:26303524 |
RGD:38676460 |
|
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
IAGP |
DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202 compared to wild type and heterozygotes |
RGD |
PMID:19500159 PMID:17803050 PMID:18676360 |
RGD:150429979, RGD:150429978, RGD:150429974 |
NCBI chr19:59,338,402...60,269,323
|
|
G |
Wwoxlde |
WW domain-containing oxidoreductase; lde mutant |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 PMID:19500159 PMID:17803050 |
RGD:150429974, RGD:150429979, RGD:150429978 |
|
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
|
IDA |
|
RGD |
PMID:12865412 |
RGD:704418 |
NCBI chr 1:87,759,631...87,762,303
|
|
|
G |
Cd36 |
CD36 molecule |
|
IAGP |
|
RGD |
PMID:9916795 |
RGD:619666 |
NCBI chr 4:18,209,088...18,302,142
|
|
|
G |
Plau |
plasminogen activator, urokinase |
treatment |
IMP |
|
RGD |
PMID:23018346 |
RGD:7241553 |
NCBI chr15:3,505,485...3,511,987
|
|
|
G |
Ccnd1 |
cyclin D1 |
|
IDA |
|
RGD |
PMID:12668975 |
RGD:704417 |
NCBI chr 1:209,518,288...209,527,986
|
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
|
RGD |
PMID:14568317 |
RGD:1626460 |
NCBI chr 3:67,370,794...67,452,422
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
IMP |
DNA:missense mutation:cds:nucleotide 1027 |
RGD |
PMID:27129673 |
RGD:150520013 |
NCBI chr 2:110,268,489...110,271,865
|
|
G |
Ghsrm1Mcwi |
growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin |
|
IMP |
compared to wild type rats |
RGD |
PMID:27129673 |
RGD:150520013 |
|
|
G |
Gnal |
G protein subunit alpha L |
|
IMP |
|
RGD |
PMID:31678405 |
RGD:150429833 |
NCBI chr18:62,892,257...63,032,510
|
|
G |
Gnalem1Hpng |
G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng |
|
IMP |
compared to wildtype controls |
RGD |
PMID:31678405 |
RGD:150429833 |
|
|
G |
Grk6 |
G protein-coupled receptor kinase 6 |
|
IMP |
associated with Parkinson Disease |
RGD |
PMID:20410529 |
RGD:5684919 |
NCBI chr17:9,182,160...9,198,380
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
|
IMP |
in hemizygote mutant male (LAMP2y/-) |
RGD |
PMID:29720683 |
RGD:13703117 |
NCBI chr X:122,038,734...122,087,745
|
|
G |
Lamp2em1 |
lysosomal-associated membrane protein 2; TALEN induced mutant1 |
|
IMP |
in hemizygote mutant male (LAMP2y/-) |
RGD |
PMID:29720683 |
RGD:13703117 |
|
|
G |
Reln |
reelin |
|
IAGP |
|
RGD |
PMID:12820163 |
RGD:729917 |
NCBI chr 4:12,736,177...13,162,956
|
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
IMP |
|
RGD |
PMID:21790898 |
RGD:150429661 |
NCBI chr 2:110,268,489...110,271,865
|
|
G |
Ghsrm1Mcwi |
growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin |
|
IMP |
compared to wild type strain FHH/EurMcwi |
RGD |
PMID:21790898 |
RGD:150429661 |
|
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
IMP |
|
RGD |
PMID:21790898 |
RGD:150429661 |
NCBI chr 2:110,268,489...110,271,865
|
|
G |
Ghsrm1Mcwi |
growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin |
|
IMP |
compared to wild type strain FHH/EurMcwi |
RGD |
PMID:21790898 |
RGD:150429661 |
|
|
|
G |
Prkg2 |
protein kinase cGMP-dependent 2 |
|
IAGP |
DNA:deletion:cds (rat) |
RGD |
PMID:15466490 |
RGD:150429792 |
NCBI chr14:10,864,020...10,972,617
|
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
IAGP |
|
RGD |
PMID:12379742 |
RGD:628338 |
NCBI chr 2:198,065,400...198,084,774
|
|
G |
Csf1tl |
colony stimulating factor 1; tooth less mutant |
|
IAGP |
|
RGD |
PMID:12379742 |
RGD:628338 |
|
|
|
G |
Fh |
fumarate hydratase |
|
IMP |
|
RGD |
PMID:27556703 |
RGD:13792708 |
NCBI chr13:90,056,565...90,082,450
|
|
G |
Fhem1 |
fumarate hydratase; TALEN induced mutant 1 |
|
IMP |
|
RGD |
PMID:27556703 |
RGD:13792708 |
|
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 PMID:34541380 |
RGD:401976418, RGD:401976419 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 PMID:34541380 |
RGD:401976418, RGD:401976419 |
|
|
|
G |
Slc9a6 |
solute carrier family 9 member A6 |
|
IMP |
|
RGD |
PMID:34928329 |
RGD:151664747 |
NCBI chr X:139,468,045...139,524,111
|
|
G |
Slc9a6 em1Moro |
solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro |
|
IMP |
|
RGD |
PMID:34928329 |
RGD:151664747 |
|
|
|
G |
Esr1 |
estrogen receptor 1 |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
NCBI chr 1:43,511,685...43,904,454
|
|
G |
Esr1em1Soar |
estrogen receptor 1; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
|
|
|
G |
Edaradd |
EDAR associated via death domain |
|
IAGP |
DNA:missense mutation:exon:p.Pro153Ser(rat) |
RGD |
PMID:22013926 |
RGD:14398762 |
NCBI chr17:85,866,629...85,910,612
|
|
G |
EdaraddswhKyo |
EDAR-associated death domain;swh Kyo mutant |
|
IAGP |
DNA:missense mutation:exon:p.Pro153Ser(rat) |
RGD |
PMID:22013926 |
RGD:14398762 |
|
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
|
IMP |
|
RGD |
PMID:16964288 |
RGD:1599505 |
NCBI chr12:4,895,092...4,939,340
|
|
G |
Brca2m1Uwm |
BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison |
|
IMP |
|
RGD |
PMID:16964288 |
RGD:1599505 |
|
|
G |
Esr1 |
estrogen receptor 1 |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
NCBI chr 1:43,511,685...43,904,454
|
|
G |
Esr1em1Soar |
estrogen receptor 1; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
|
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
IMP |
|
RGD |
PMID:30893315 |
RGD:126908018 |
NCBI chr 4:169,491,273...169,496,500
|
|
G |
Cdkn1bem1Musc |
cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc |
|
IMP |
|
RGD |
PMID:30893315 |
RGD:126908018 |
|
|
G |
Cdkn1bem4Musc |
cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc |
|
IMP |
|
RGD |
PMID:30893315 |
RGD:126908018 |
|
|
|
G |
Cacna1f |
calcium voltage-gated channel subunit alpha1 F |
|
IAGP |
DNA:mutation:cds: c.2941C>T |
RGD |
PMID:22800190 |
RGD:13792551 |
NCBI chr X:14,868,096...14,896,413
|
|
G |
Cacna1f csnb |
calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant |
|
IAGP |
DNA:mutation:cds: c.2941C>T |
RGD |
PMID:22800190 |
RGD:13792551 |
|
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 |
RGD:401976418 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 |
RGD:401976418 |
|
|
|
G |
Spata22 |
spermatogenesis associated 22 |
treatment |
IDA |
|
RGD |
PMID:23903057 |
RGD:38549346 |
NCBI chr10:57,945,272...57,963,081
|
|
|
G |
Atm |
ATM serine/threonine kinase |
|
IMP |
|
RGD |
PMID:28007901 |
RGD:12879399 |
NCBI chr 8:62,724,939...62,829,040
|
|
G |
Atmem1Kyo |
ATM serine/threonine kinase; ZFN induced mutant 1, Kyo |
|
IMP |
|
RGD |
PMID:28007901 |
RGD:12879399 |
|
|
|
G |
Atm |
ATM serine/threonine kinase |
|
IMP |
DNA:deletion:exon: |
RGD |
PMID:28007901 |
RGD:12879399 |
NCBI chr 8:62,724,939...62,829,040
|
|
G |
Atmem1Kyo |
ATM serine/threonine kinase; ZFN induced mutant 1, Kyo |
|
IMP |
|
RGD |
PMID:28007901 |
RGD:12879399 |
|
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
IMP |
|
RGD |
PMID:22629444 |
RGD:7240532 |
NCBI chr 7:95,483,105...95,488,031
|
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
|
IMP |
in hemizygote mutant male (LAMP2y/-) |
RGD |
PMID:28124283 |
RGD:13703118 |
NCBI chr X:122,038,734...122,087,745
|
|
G |
Lamp2em1 |
lysosomal-associated membrane protein 2; TALEN induced mutant1 |
|
IMP |
in hemizygote mutant male (LAMP2y/-) |
RGD |
PMID:28124283 |
RGD:13703118 |
|
|
|
G |
Edaradd |
EDAR associated via death domain |
|
IAGP |
DNA:missense mutation:exon:p.Pro153Ser(rat) |
RGD |
PMID:22013926 |
RGD:14398762 |
NCBI chr17:85,866,629...85,910,612
|
|
G |
EdaraddswhKyo |
EDAR-associated death domain;swh Kyo mutant |
|
IAGP |
DNA:missense mutation:exon:p.Pro153Ser(rat) |
RGD |
PMID:22013926 |
RGD:14398762 |
|
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
IAGP |
|
RGD |
PMID:12629505 |
RGD:1358549 |
NCBI chr 7:115,762,662...115,771,832
|
|
|
G |
Bace1 |
beta-secretase 1 |
|
IMP |
|
RGD |
PMID:28281673 |
RGD:13782149 |
NCBI chr 8:55,038,842...55,061,138
|
|
G |
Bace1em1Sage |
|
|
IMP |
|
RGD |
PMID:28281673 |
RGD:13782149 |
|
|
G |
Mecp2 |
methyl CpG binding protein 2 |
|
IMP |
compared to SD wild-type |
RGD |
PMID:27329765 |
RGD:40924662 |
NCBI chr X:156,932,481...156,995,981
|
|
G |
Mecp2em1Sage |
methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
compared to SD wild-type |
RGD |
PMID:27329765 |
RGD:40924662 |
|
|
G |
Park7 |
Parkinsonism associated deglycase |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
NCBI chr 5:166,636,551...166,659,825
|
|
G |
Park7em1Sage |
parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
|
|
G |
Pink1 |
PTEN induced kinase 1 |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
NCBI chr 5:155,813,838...155,825,950
|
|
G |
Pink1em1Sage |
PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
|
|
|
G |
Gnal |
G protein subunit alpha L |
|
IMP |
|
RGD |
PMID:31678405 |
RGD:150429833 |
NCBI chr18:62,892,257...63,032,510
|
|
G |
Gnalem1Hpng |
G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng |
|
IMP |
compared to wildtype controls |
RGD |
PMID:31678405 |
RGD:150429833 |
|
|
G |
Ube3a |
ubiquitin protein ligase E3A |
|
IMP |
|
RGD |
PMID:32066685 |
RGD:126790466 |
NCBI chr 1:119,204,244...119,297,097
|
|
G |
Ube3aem1Jue |
ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue |
|
IMP |
|
RGD |
PMID:32066685 |
RGD:126790466 |
|
|
|
G |
Cplx1 |
complexin 1 |
|
IMP |
|
RGD |
PMID:31875236 |
RGD:127285808 |
NCBI chr14:1,184,677...1,216,392
|
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
compared to wild type |
RGD |
PMID:34541380 |
RGD:401976419 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
|
IMP |
compared to wild type |
RGD |
PMID:34541380 |
RGD:401976419 |
|
|
|
G |
Crb1 |
crumbs cell polarity complex component 1 |
|
IAGP |
|
RGD |
PMID:25878282 |
RGD:13451131 |
NCBI chr13:53,352,932...53,540,019
|
|
G |
Crb1m1 |
crumbs 1, cell polarity complex component, mutant 1 |
|
IAGP |
|
RGD |
PMID:25878282 |
RGD:13451131 |
|
|
|
G |
Park7 |
Parkinsonism associated deglycase |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
NCBI chr 5:166,636,551...166,659,825
|
|
G |
Park7em1Sage |
parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
|
|
G |
Pink1 |
PTEN induced kinase 1 |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
NCBI chr 5:155,813,838...155,825,950
|
|
G |
Pink1em1Sage |
PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
|
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 |
RGD:401976418 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 |
RGD:401976418 |
|
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 |
RGD:401976418 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 |
RGD:401976418 |
|
|
|
G |
Myh7b |
myosin heavy chain 7B |
|
IMP |
|
RGD |
PMID:32207065 |
RGD:126925946 |
NCBI chr 3:144,076,911...144,122,714
|
|
G |
Myh7bem1Blar |
myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar |
|
IMP |
|
RGD |
PMID:32207065 |
RGD:126925946 |
|
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
IMP |
|
RGD |
PMID:24608905 |
RGD:11566051 |
NCBI chr 4:47,422,084...47,694,646
|
|
G |
Cftrem1Sage |
cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage |
|
IMP |
|
RGD |
PMID:24608905 |
RGD:11566051 |
|
|
|
G |
Depdc5 |
DEP domain containing 5, GATOR1 subcomplex subunit |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
NCBI chr14:81,956,777...82,087,392
|
|
G |
Depdc5em1Kyo |
DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
|
|
G |
Depdc5em2Kyo |
DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
|
|
|
G |
Depdc5 |
DEP domain containing 5, GATOR1 subcomplex subunit |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
NCBI chr14:81,956,777...82,087,392
|
|
G |
Depdc5em1Kyo |
DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
|
|
G |
Depdc5em2Kyo |
DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
|
|
|
G |
Depdc5 |
DEP domain containing 5, GATOR1 subcomplex subunit |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
NCBI chr14:81,956,777...82,087,392
|
|
G |
Depdc5em1Kyo |
DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
|
|
G |
Depdc5em2Kyo |
DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo |
|
IMP |
|
RGD |
PMID:26873552 |
RGD:11573213 |
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
IMP |
compared to wild type controls |
RGD |
PMID:26166728 |
RGD:11080370 |
NCBI chr X:147,240,239...147,278,057
|
|
G |
Fmr1em1Sage |
FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
compared to wild type controls |
RGD |
PMID:26166728 |
RGD:11080370 |
|
|
|
G |
Mir195 |
microRNA 195 |
|
IMP |
in hippocampus |
RGD |
PMID:32272873 |
RGD:45073134 |
NCBI chr10:54,951,838...54,951,924
|
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
IMP |
knock-out compared to wild-type rats knockout compared to wild type |
RGD |
PMID:30283001 PMID:28700935 |
RGD:38501063, RGD:38501064 |
NCBI chr 8:116,158,810...116,171,857
|
|
G |
Grm2em1 |
glutamate metabotropic receptor 2; endonuclease induced mutant 1 |
|
IMP |
KO compared to wild-type rats |
RGD |
PMID:28700935 PMID:30283001 |
RGD:38501064, RGD:38501063 |
|
|
|
G |
Il1rl2 |
interleukin 1 receptor-like 2 |
|
IMP |
compared to Wild Type in cardiopulmonary bypass model |
RGD |
PMID:32048631 |
RGD:126925167 |
NCBI chr 9:42,591,658...42,639,351
|
|
G |
Il1rl2tm1(Myh6-cre)Mhzh |
interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh |
|
IMP |
compared to Wild Type in cardiopulmonary bypass model |
RGD |
PMID:32048631 |
RGD:126925167 |
|
|
|
G |
Aire |
autoimmune regulator |
|
IMP |
|
RGD |
PMID:29959280 |
RGD:38599145 |
NCBI chr20:10,635,775...10,650,709
|
|
G |
Aireem1Ang |
autoimmune regulator; ZFN induced mutant1, Ang |
|
IMP |
|
RGD |
PMID:29959280 |
RGD:38599145 |
|
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
|
IDA |
|
RGD |
PMID:12126749 |
RGD:1582348 |
NCBI chr 2:26,869,343...26,885,856
|
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
IMP |
knock-out compared to wild-type rats |
RGD |
PMID:30283001 |
RGD:38501063 |
NCBI chr 8:116,158,810...116,171,857
|
|
G |
Grm2em1 |
glutamate metabotropic receptor 2; endonuclease induced mutant 1 |
|
IMP |
KO compared to wild-type rats |
RGD |
PMID:30283001 |
RGD:38501063 |
|
|
|
G |
Nlgn3 |
neuroligin 3 |
|
IMP |
during light cycle |
RGD |
PMID:28958035 |
RGD:126790492 |
NCBI chr X:66,427,926...66,457,378
|
|
G |
Nlgn3em1Sage |
neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
during light cycle |
RGD |
PMID:28958035 |
RGD:126790492 |
|
|
|
G |
Pax6 |
paired box 6 |
|
IAGP |
|
RGD |
PMID:7981749 |
RGD:1601213 |
NCBI chr 3:92,128,772...92,157,022
|
|
G |
Pax6Sey |
paired box gene 6, small eye mutation |
|
IAGP |
|
RGD |
PMID:7981749 |
RGD:1601213 |
|
|
|
G |
Adcy3 |
adenylate cyclase 3 |
|
IDA |
|
RGD |
PMID:2255909 |
RGD:70798 |
NCBI chr 6:32,819,602...32,923,174
|
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
IMP |
|
RGD |
PMID:31942562 |
RGD:126928119 |
NCBI chr 4:47,422,084...47,694,646
|
|
G |
Cftrem1Ang |
cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang |
|
IMP |
|
RGD |
PMID:31942562 |
RGD:126928119 |
|
|
G |
Cftrem2Ang |
cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang |
|
IMP |
|
RGD |
PMID:31942562 |
RGD:126928119 |
|
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
IMP |
DNA:deletion:intron 7, exon 8: |
RGD |
PMID:30877790 |
RGD:38548928 |
NCBI chr X:147,240,239...147,278,057
|
|
G |
Fmr1em1Sage |
FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
DNA:deletion:intron 7, exon 8: |
RGD |
PMID:30877790 |
RGD:38548928 |
|
|
G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
|
IMP |
|
RGD |
PMID:29970986 |
RGD:126790534 |
NCBI chr 1:208,575,144...209,020,300
|
|
G |
Shank2em13Sage |
SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage |
|
IMP |
|
RGD |
PMID:29970986 |
RGD:126790534 |
|
|
|
G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
|
IAGP |
|
RGD |
PMID:27727328 |
RGD:40924666 |
NCBI chr 8:57,885,886...58,073,507
|
|
|
G |
Atm |
ATM serine/threonine kinase |
|
IMP |
DNA:deletion:exon: |
RGD |
PMID:27895165 PMID:28007901 |
RGD:12879393, RGD:12879399 |
NCBI chr 8:62,724,939...62,829,040
|
|
G |
Atmem1Kyo |
ATM serine/threonine kinase; ZFN induced mutant 1, Kyo |
|
IMP |
|
RGD |
PMID:28007901 |
RGD:12879399 |
|
|
G |
Atmm1Kyo |
ATM serine/threonine kinase; ENU induced mutant 1, Kyo |
|
IMP |
|
RGD |
PMID:27895165 |
RGD:12879393 |
|
|
|
G |
Lepr |
leptin receptor |
treatment |
IAGP |
|
RGD |
PMID:33568522 |
RGD:401965412 |
NCBI chr 5:121,409,735...121,593,201
|
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
|
RGD |
PMID:14568317 |
RGD:1626460 |
NCBI chr 3:67,370,794...67,452,422
|
|
G |
Scn9a |
sodium voltage-gated channel alpha subunit 9 |
induces |
IMP |
|
RGD |
PMID:31550995 |
RGD:150429745 |
NCBI chr 3:71,553,185...71,701,377
|
|
G |
Scn9a*tm1Amgn |
sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn |
induces |
IMP |
|
RGD |
PMID:31550995 |
RGD:150429745 |
|
|
|
G |
Pax6 |
paired box 6 |
|
IAGP |
|
RGD |
PMID:17178107 |
RGD:12790972 |
NCBI chr 3:92,128,772...92,157,022
|
|
|
G |
Nlgn3 |
neuroligin 3 |
|
IMP |
during light cycle |
RGD |
PMID:28958035 |
RGD:126790492 |
NCBI chr X:66,427,926...66,457,378
|
|
G |
Nlgn3em1Sage |
neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
during light cycle |
RGD |
PMID:28958035 |
RGD:126790492 |
|
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
|
RGD |
PMID:14568317 |
RGD:1626460 |
NCBI chr 3:67,370,794...67,452,422
|
|
G |
Kdr |
kinase insert domain receptor |
|
IDA |
|
RGD |
PMID:15258583 |
RGD:1581594 |
NCBI chr14:32,572,031...32,615,204
|
|
|
G |
Hr |
HR, lysine demethylase and nuclear receptor corepressor |
|
IMP |
|
RGD |
PMID:21325752 |
RGD:150520024 |
NCBI chr15:45,626,835...45,646,313
|
|
|
G |
Foxo4 |
forkhead box O4 |
|
IMP |
|
RGD |
PMID:36607602 |
RGD:158013768 |
NCBI chr X:66,385,241...66,392,115
|
|
G |
Foxo4em1Soar |
forkhead box O4; CRISPR/Cas9 induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:36607602 |
RGD:158013768 |
|
|
G |
Il15 |
interleukin 15 |
|
IMP |
|
RGD |
PMID:28395334 |
RGD:12910490 |
NCBI chr19:42,536,160...42,611,349
|
|
G |
Il15em1Soar |
interleukin 15; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:28395334 |
RGD:12910490 |
|
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
|
RGD |
PMID:34320241 |
RGD:401976418 |
NCBI chr X:102,062,497...102,073,915
|
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
|
RGD |
PMID:34320241 |
RGD:401976418 |
NCBI chr X:102,062,497...102,073,915
|
|
|
G |
Rab38 |
RAB38, member RAS oncogene family |
|
IAGP |
|
RGD |
PMID:18983523 |
RGD:2324691 |
NCBI chr 1:142,182,566...142,262,923
|
|
G |
Rab38ru |
Rab38, member of RAS oncogene family, ruby allele |
|
IAGP |
|
RGD |
PMID:18983523 |
RGD:2324691 |
|
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 |
RGD:401976418 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
|
IMP |
compared to wild type |
RGD |
PMID:34320241 |
RGD:401976418 |
|
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
ameliorates |
IMP |
associated with Experimental Diabetes Mellitus, compared to wild type SS |
RGD |
PMID:37643020 |
RGD:401827835 |
NCBI chr19:30,327,643...30,355,856
|
|
G |
Mmp2em2Mcwi |
matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
ameliorates |
IMP |
associated with Experimental Diabetes Mellitus, compared to wild type SS |
RGD |
PMID:37643020 |
RGD:401827835 |
|
|
|
G |
P2ry2 |
purinergic receptor P2Y2 |
|
IMP |
|
RGD |
PMID:19155635 |
RGD:2316657 |
NCBI chr 1:164,764,119...164,779,578
|
|
|
G |
Klf5 |
KLF transcription factor 5 |
|
IMP |
|
RGD |
PMID:32272873 |
RGD:45073134 |
NCBI chr15:76,060,320...76,079,445
|
|
G |
Mir195 |
microRNA 195 |
|
IMP |
|
RGD |
PMID:32272873 |
RGD:45073134 |
NCBI chr10:54,951,838...54,951,924
|
|
|
G |
Cntnap2 |
contactin associated protein 2 |
|
IMP |
worsens with age |
RGD |
PMID:30126973 |
RGD:126790476 |
NCBI chr 4:74,109,455...76,366,434
|
|
G |
Cntnap2em1Sage |
contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
worsens with age |
RGD |
PMID:30126973 |
RGD:126790476 |
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
no_association sexual_dimorphism |
IAGP |
compared to wild type controls in wild type controls |
RGD |
PMID:32144356 PMID:32144356 |
RGD:35668860, RGD:35668860 |
NCBI chr X:147,240,239...147,278,057
|
|
G |
Fmr1em2Mcwi |
FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin |
no_association sexual_dimorphism |
IAGP |
compared to wild type controls in wild type controls |
RGD |
PMID:32144356 PMID:32144356 |
RGD:35668860, RGD:35668860 |
|
|
|
G |
Esr2 |
estrogen receptor 2 |
|
IMP |
|
RGD |
PMID:28520870 |
RGD:38548924 |
NCBI chr 6:100,589,553...100,645,240
|
|
G |
Esr2em1Soar |
estrogen receptor 2; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:28520870 |
RGD:38548924 |
|
|
|
G |
Klf5 |
KLF transcription factor 5 |
|
IMP |
Syp, Gap43 |
RGD |
PMID:32272873 |
RGD:45073134 |
NCBI chr15:76,060,320...76,079,445
|
|
G |
Mir195 |
microRNA 195 |
|
IMP |
Syp, Gap43 |
RGD |
PMID:32272873 |
RGD:45073134 |
NCBI chr10:54,951,838...54,951,924
|
|
|
G |
Ctns |
cystinosin, lysosomal cystine transporter |
|
IMP |
|
RGD |
PMID:35695380 |
RGD:155630629 |
NCBI chr10:58,300,069...58,315,725
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
|
RGD |
PMID:29979634 |
RGD:401976416 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:29979634 |
RGD:401976416 |
|
|
|
G |
Kcnk3 |
potassium two pore domain channel subfamily K member 3 |
|
IMP |
|
RGD |
PMID:31347976 |
RGD:151347452 |
NCBI chr 6:25,761,487...25,799,153
|
|
G |
Kcnk3em1Ang |
potassium two pore domain channel subfamily K member 3; CRISPR/Cas9 induced mutant1, Ang |
|
IMP |
|
RGD |
PMID:31347976 |
RGD:151347452 |
|
|
|
G |
Mecp2 |
methyl CpG binding protein 2 |
|
IMP |
|
RGD |
PMID:27313794 |
RGD:11568037 |
NCBI chr X:156,932,481...156,995,981
|
|
G |
Mecp2em1Sage |
methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:27313794 |
RGD:11568037 |
|
|
|
G |
Hcn1 |
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 |
|
IMP |
|
RGD |
PMID:30408474 |
RGD:26923909 |
NCBI chr 2:49,495,771...49,899,983
|
|
G |
Hcn1em1Kyo |
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo |
|
IMP |
|
RGD |
PMID:30408474 |
RGD:26923909 |
|
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
|
IMP |
|
RGD |
PMID:32841724 |
RGD:150530292 |
NCBI chr 8:55,369,794...55,398,526
|
|
G |
Chrna5em18Pas |
cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 18,Pas |
|
IMP |
|
RGD |
PMID:32841724 |
RGD:150530292 |
|
|
|
G |
P2rx7 |
purinergic receptor P2X 7 |
|
IMP |
|
RGD |
PMID:31630543 |
RGD:14995937 |
NCBI chr12:39,550,531...39,594,984
|
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
IMP |
|
RGD |
PMID:24722447 |
RGD:12910103 |
NCBI chr 7:132,368,399...132,389,300
|
|
|
G |
Add3 |
adducin 3 |
|
IMP |
|
RGD |
PMID:32029431 |
RGD:150340736 |
NCBI chr 1:262,152,722...262,260,504
|
|
G |
Col4a5 |
collagen type IV alpha 5 chain |
|
IMP |
|
RGD |
PMID:34675305 |
RGD:329845598 |
NCBI chr X:109,907,251...110,111,214
|
|
G |
Ctns |
cystinosin, lysosomal cystine transporter |
|
IMP |
|
RGD |
PMID:35695380 |
RGD:155630629 |
NCBI chr10:58,300,069...58,315,725
|
|
G |
P2ry2 |
purinergic receptor P2Y2 |
|
IMP |
|
RGD |
PMID:19155635 |
RGD:2316657 |
NCBI chr 1:164,764,119...164,779,578
|
|
|
G |
Ctns |
cystinosin, lysosomal cystine transporter |
|
IMP |
|
RGD |
PMID:35695380 |
RGD:155630629 |
NCBI chr10:58,300,069...58,315,725
|
|
|
G |
Atp7b |
ATPase copper transporting beta |
|
IAGP |
|
RGD |
PMID:11509115 |
RGD:1302456 |
NCBI chr16:76,654,725...76,726,092
|
|
G |
Atp7bhts |
ATPase copper transporting beta; hepatitis |
|
IAGP |
|
RGD |
PMID:11509115 |
RGD:1302456 |
|
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
treatment |
IAGP |
|
RGD |
PMID:1127102 |
RGD:1354700 |
NCBI chr 9:96,249,143...96,256,264
|
|
G |
Ugt1a1j |
UDP glucuronosyltransferase family 1 member A1, jaundice mutant |
treatment |
IAGP |
|
RGD |
PMID:1127102 |
RGD:1354700 |
|
|
|
G |
Esr1 |
estrogen receptor 1 |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
NCBI chr 1:43,511,685...43,904,454
|
|
|
G |
Isca1 |
iron-sulfur cluster assembly 1 |
|
IMP |
|
RGD |
PMID:31016283 |
RGD:39131292 |
NCBI chr17:4,905,291...4,917,955
|
|
|
G |
Tbc1d1 |
TBC1 domain family member 1 |
induces |
IMP |
|
RGD |
PMID:28808062 |
RGD:150521563 |
NCBI chr14:44,289,241...44,489,246
|
|
G |
Tbc1d1Tn(sb)1Fkh |
TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh |
induces |
IMP |
|
RGD |
PMID:28808062 |
RGD:150521563 |
|
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
IMP |
knockout compared to wild type |
RGD |
PMID:28700935 |
RGD:38501064 |
NCBI chr 8:116,158,810...116,171,857
|
|
G |
Grm2em1 |
glutamate metabotropic receptor 2; endonuclease induced mutant 1 |
|
IMP |
KO compared to wild-type rats |
RGD |
PMID:28700935 |
RGD:38501064 |
|
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
|
IMP |
|
RGD |
PMID:33293518 |
RGD:158012686 |
NCBI chr 3:75,777,260...75,818,099
|
|
G |
Gad1em15Yyan |
glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan |
|
IMP |
|
RGD |
PMID:33293518 |
RGD:158012686 |
|
|
|
G |
Drd1 |
dopamine receptor D1 |
|
IMP |
compared t |